| 5′-FU | 5′-fluorouracil |
| APCs | antigen presenting cells |
| ATX | autotaxin |
| BM | basement membrane |
| BM-MSCs | bone marrow-derived mesenchymal stem cells |
| CAFs | cancer associated fibroblasts |
| CA-MSC | cancer-associated MSC |
| CB2 | cannabinoid receptor 2 |
| CAIX | carbonic anhydrase |
| CCL2 | chemokine (C-C motif) ligand 2 |
| CTCs | circulating tumor cells |
| CTMs | circulating tumor microemboli |
| CSF-1 | colony-stimulating factor-1 |
| CRC | colorectal cancer |
| PDAC | pancreatic ductal adenocarcinoma |
| endMT | endothelial-to-mesenchymal transition |
| EMT | epithelial-to-mesenchymal transition |
| ECM | extracellular matrix |
| FAP | fibroblast activation protein |
| GC-MSCs | gastric cancer tissue-related mesenchymal stem cells |
| AuNPs | gold nanoparticles |
| GPCRs | G-protein coupled receptors |
| GM-CSF | granulocyte-macrophage colony-stimulating factor |
| HNSCC | head and neck squamous cell carcinoma |
| HSC | hematopoietic stem cells |
| HCC | hepatocellular carcinoma |
| IMs | inflammatory monocytes |
| IFN-γ | interferon-γ |
| KCNN4 | intermediate-conductance Ca2+-activated potassium channels |
| LECs | lymphatic endothelial cells |
| LPA | lysophosphatidic acid |
| LOX | lysyl oxidase |
| MMPs | matrix metalloproteinases |
| MSCs | mesenchymal stem cells |
| MMT | mesenchymal-mesenchymal transition |
| MAMs | metastasis-associated macrophages |
| NPs | nanoparticles |
| NK | natural killer cells |
| NSCLC | non-small cell lung cancer cells |
| PDX | patient-derived xenograft mouse |
| PD-L1 | programmed death-ligand 1 |
| PRL-3 | phosphatase of regenerating liver |
| S-TRAIL | secretable tumor necrosis factor apoptosis inducing ligand |
| sECM | synthetic extracellular matrix |
| TSP | thrombospondin |
| TLRs | toll-like Receptors |
| TME | tumor microenvironment |
| TMEM | tumor microenvironment of metastasis |
| TNF-α | tumor necrosis factor-α |
| TAMs | tumor-associated macrophages |
| VCAM-1 | vascular cell adhesion molecule-1 |
| α-SMA | α-smooth muscle actin |